Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development a Pulmonary Nodules Diagnosis Classification Model for Benign/Malignant of Bronchoscopic Biopsy Specimens Based on High-throughput Whole-genome Methylation Sequencing(GM-seq)

NCT05415670 is registered in ClinicalTrials.gov with Geneplus-Beijing Co. Ltd. as lead sponsor.

NCT NCT05415670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05415670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development a Pulmonary Nodules Diagnosis Classification Model for Benign/Malignant of Bronchoscopic Biopsy Specimens Based on High-throughput Whole-genome Methylation Sequencing(GM-seq)
Lead sponsor
Geneplus-Beijing Co. Ltd.
Phase
Observational
Overall status
Completed
Start date
July 1, 2023
Completion date
August 1, 2025
Enrollment
158 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary nodule, solitary, whole-genome methylation sequencing